Form Type: 4

SEC EDGAR Link
Accession Number:0001144204-15-059043
Date:2015-10-12
Issuer: IMMUNE PHARMACEUTICALS INC (IMNP)
Original Submission Date:

Reporting Person:

TEPER DANIEL GEDEON
C/O IMMUNE PHARMACEUTICALS INC.
430 EAST 29TH STREET, SUITE 940 NEW YORK, NY 10016

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2015-10-12 P 19,000 a $1.30 4,520,905 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the transaction reported in this line item was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on september 15, 2015.
WhaleWisdom Logo

Elevate your investments